Shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN – Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $10.13 and traded as high as $13.22. Cross Country Healthcare shares last traded at $13.21, with a volume of 218,796 shares traded.
Analyst Ratings Changes
A number of research analysts recently commented on the stock. Citigroup downgraded shares of Cross Country Healthcare from a “market outperform” rating to a “market perform” rating in a research report on Thursday, May 7th. Truist Financial increased their target price on shares of Cross Country Healthcare from $10.00 to $13.25 and gave the stock a “hold” rating in a research report on Monday, May 11th. Weiss Ratings raised shares of Cross Country Healthcare from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, May 27th. Barrington Research restated a “market perform” rating and set a $13.25 price target on shares of Cross Country Healthcare in a report on Monday, June 8th. Finally, Cross Research set a $14.00 price target on shares of Cross Country Healthcare in a report on Thursday, March 5th. Nine analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Cross Country Healthcare has an average rating of “Reduce” and a consensus price target of $12.05.
Check Out Our Latest Stock Analysis on Cross Country Healthcare
Cross Country Healthcare Price Performance
Cross Country Healthcare (NASDAQ:CCRN – Get Free Report) last posted its earnings results on Thursday, May 7th. The business services provider reported ($0.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02. The firm had revenue of $241.06 million during the quarter, compared to analysts’ expectations of $237.06 million. Cross Country Healthcare had a negative net margin of 9.84% and a negative return on equity of 0.74%. On average, analysts expect that Cross Country Healthcare, Inc. will post 0.09 EPS for the current year.
Institutional Investors Weigh In On Cross Country Healthcare
Large investors have recently bought and sold shares of the business. JPMorgan Chase & Co. increased its position in Cross Country Healthcare by 42.8% during the third quarter. JPMorgan Chase & Co. now owns 294,845 shares of the business services provider’s stock worth $4,187,000 after buying an additional 88,407 shares during the last quarter. Dana Investment Advisors Inc. lifted its position in shares of Cross Country Healthcare by 71.2% in the fourth quarter. Dana Investment Advisors Inc. now owns 1,008,525 shares of the business services provider’s stock worth $8,169,000 after buying an additional 419,429 shares during the last quarter. Prescott Group Capital Management L.L.C. acquired a new stake in shares of Cross Country Healthcare in the fourth quarter worth about $2,292,000. Pinnacle Associates Ltd. bought a new stake in shares of Cross Country Healthcare during the 4th quarter worth about $717,000. Finally, Vestcor Inc boosted its stake in shares of Cross Country Healthcare by 2,452.7% during the 3rd quarter. Vestcor Inc now owns 61,519 shares of the business services provider’s stock worth $874,000 after acquiring an additional 59,109 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors.
Cross Country Healthcare Company Profile
Cross Country Healthcare, Inc, headquartered in Boca Raton, Florida, is a leading provider of healthcare workforce solutions in the United States. The company specializes in the recruitment, placement and management of nursing and allied health professionals on both a travel and permanent basis. Through its integrated platform, Cross Country Healthcare serves hospitals, health systems, and long-term care facilities by matching qualified clinical talent with patient care needs across diverse care settings.
The company’s core service offerings include travel nurse and allied health staffing, per diem staffing, permanent placement services, and managed services programs.
See Also
- Five stocks we like better than Cross Country Healthcare
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
